China Universal Asset Management »

Y Mabs Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $136k 8.4k 16.21
2023-12-31 $34k 5.1k 6.73
2022-09-30 $6.0k 410 14.63

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Y Mabs Therapeutics

Vanguard Group
D. E. Shaw & Co
Caligan Partners
Acadian Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Two Sigma Advisers
Soleus Capital Management
Citadel Advisors
Thomas Stevens, CFA"
Marshall Wace
Bank of New York Mellon

View all funds holding Y Mabs Therapeutics